Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability and Food Effect of Ipatasertib in Healthy Subjects
NCT02536391Phase 1Completed
- Sponsor
- Genentech
- Start
- Oct 2015
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ipatasertib in cancer (6 arms), sponsored by Genentech. Primary endpoints: Maximum Observed Concentration at Day 15, Time to Maximum Concentration at Day 15 and 5 more. Started Oct 2015; status: completed.
02
Drugs
ipatasertib
03
Conditions
cancer
Beyond the preview
Go deeper on NCT02536391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02536391.